Table 1.

Available pharmacological treatment options for Parkinson’s disease

Pharmacological treatments for Parkinson’s disease
Dopamine precursor
Carbidopa/levodopa (Sinemet®, Parcopa®, generics)
Carbidopa/levodopa extended release (Sinemet CR®, generics)
Dopamine agonists
Ropinirole (Requip®, generic)
Ropinirole prolonged release (Requip XL®)
Pramipexole (Mirapex®)
Rotigotine patch (Neupro®)
Apomorphine injections (Apokyn®)
MAO-B inhibitors
Rasagiline (Azilect®)
Selegiline (Eldepryl®)
Orally disintegrating selegiline (Zelapar®)
COMT inhibitors
Entacapone (Comtan®)
Carbidopa/levodopa/entacapone (Stalevo®)
Tolcapone (Tasmar®)
Anticholinergics
Benztropine (Cogentin®)
Trihexyphenidyl (Artane®)
Antiglutamatergics
Amantadine (Symmetrel®)

Abbreviations: COMT, catechol-O-methyltransferase; MAO-B, monoamine oxidase type B.